Skip to content

13F-HR filed by Sio Capital Management, LLC

Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-13, with 34 holding rows worth $145,891,000.

Accession
0001214659-15-007746
Filed
2015-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 35 entries on the cover page, a total value of $145,891,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $145,891,000 with VALUE read as thousands by filing date, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
QUOTIENT LTDG73268107SHS1,580,457$16,668,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM666,729$14,008,000thousands by filing date
Johnson & Johnson478160104COM85,438$7,976,000thousands by filing date
Medtronic PlcG5960L103COM113,289$7,584,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM94,868$7,288,000thousands by filing date
UnitedHealth Group Inc91324P102COM55,984$6,495,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR131,271$6,231,000thousands by filing date
CIGNA CORPORATION125509109COM45,493$6,142,000thousands by filing date
IGNYTA INC451731103COM682,306$5,991,000thousands by filing date
Amgen Inc.031162100COM37,832$5,233,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock64,996$5,223,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares856,072$5,213,000thousands by filing date
AbbVie,Inc.00287Y109COM94,316$5,132,000thousands by filing date
ADAMIS PHARMACEUTICALS CORP00547W208COM NEW1,306,860$5,058,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock37,677$4,945,000thousands by filing date
Bristol-Myers Squibb Company110122108COM82,734$4,898,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR269,785$4,775,000thousands by filing date
FLAMEL TECHNOLOGIES-SP ADR338488109SPON239,698$3,909,000thousands by filing date
PFENEX INC717071104COM255,303$3,832,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM364,368$2,518,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS336,286$2,465,000thousands by filing date
CYBERONICS23251P102COMMON STOCK40,478$2,460,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM57,605$1,983,000thousands by filing date
NATUS MEDICAL INC639050103COM50,000$1,973,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM101,766$1,704,000thousands by filing date
HANGER INC41043F208COMMON STOCK91,995$1,255,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM140,156$1,186,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock162,175$1,181,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK107,400$1,119,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM79,567$536,000thousands by filing date
INSPIREMD INC45779A507Cmn2,166,446$357,000thousands by filing date
IMMUNE PHARMACEUTICALS INC45254C101COM197,655$233,000thousands by filing date
CONCORDIA HEALTHCARE CORP206519100COM5,201$221,000thousands by filing date
HARVARD APPARATUS REGENER TE41690A106COM116,593$99,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-15-007746this filing2015-11-13acceptance time not in the bulk data set